| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||||
Net loss | ||||||||||
-3,146 | -1,740 | 40,589 | -2,868 | -3,600 | -7,834 | 405 | -1,091 | -2,710 | -3,501 | -3,842 |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||||
Realized loss on marketable debt securities | ||||||||||
-12 | -130 | - | - | - | - | - | - | - | - | - |
Loss on discontinued operations, net of taxes | ||||||||||
-40 | -170 | 42,301 | - | - | - | - | - | - | - | - |
Loss (gain) on sale of assets, net of taxes | ||||||||||
- | - | - | 0 | 9 | 6 | 0 | 0 | 28 | 0 | -104 |
Change in valuation allowance, income tax | ||||||||||
- | - | 1,421 | 0 | 0 | - | - | - | - | - | - |
Depreciation and amortization | ||||||||||
398 | 383 | 337 | - | - | 277 | - | - | 355 | 363 | 522 |
Depreciation | ||||||||||
- | - | - | 426 | 367 | - | 243 | 252 | - | - | - |
Loss on fixed asset disposal | ||||||||||
- | - | -291 | 0 | 0 | - | - | - | - | - | - |
Amortization of loan origination and warrant expenses | ||||||||||
- | - | -10 | -24 | - | 0 | - | - | - | - | - |
Reduction of payment obligation, settlement benefit | ||||||||||
- | - | - | - | - | - | - | 1,024 | 0 | 0 | - |
Impairment charge | ||||||||||
- | - | - | - | - | 3,577 | 0 | 0 | - | - | 74 |
Stock-based compensation expense | ||||||||||
744 | 634 | 78 | 1 | 135 | 1,044 | 269 | 246 | 631 | 192 | 0 |
Changes in operating assets and liabilities: | ||||||||||
Sales discounts and provision for bad debts | ||||||||||
- | - | - | - | - | - | - | - | - | - | 133 |
Inventory valuation provision | ||||||||||
- | - | - | - | - | - | - | - | - | - | -633 |
Accounts receivable | ||||||||||
-936 | 1,023 | -3,825 | 1,770 | -1,836 | 517 | -90 | 2,190 | -1,602 | 1,222 | -2,485 |
Inventory | ||||||||||
-444 | 372 | -1,205 | -1,595 | 1,039 | 771 | 470 | -637 | 1,006 | 277 | -963 |
Prepaid and other assets | ||||||||||
8 | -185 | -199 | -1,204 | 480 | -397 | -886 | 940 | 864 | 68 | -390 |
Accounts payable and accrued expenses | ||||||||||
-14 | -125 | -1,594 | - | - | - | - | - | - | - | - |
Accounts payable | ||||||||||
- | - | - | 1,166 | 323 | -344 | -285 | 411 | 396 | -219 | -109 |
Income tax payable | ||||||||||
- | - | - | 0 | 0 | - | - | - | - | - | - |
Accrued advertising and other allowances | ||||||||||
- | -99 | -2,605 | 297 | -1,177 | 838 | 87 | -199 | -565 | 1,384 | -597 |
Due to Mylan, Inc. and affiliates | ||||||||||
- | 59 | -59 | - | - | - | - | - | - | - | - |
Other current liabilities | ||||||||||
-247 | -225 | -1,488 | - | - | - | - | - | - | - | - |
Accrued royalties and commissions | ||||||||||
- | - | - | - | - | - | - | -2,100 | 0 | 0 | - |
Other operating assets and liabilities, net | ||||||||||
- | - | - | 547 | -147 | -123 | 88 | -269 | -81 | 201 | 45 |
Accrued sales allowance, discontinued operations | ||||||||||
- | - | - | 0 | 0 | - | - | - | - | - | - |
Assets held for sale | ||||||||||
- | -22 | 22 | 0 | 0 | - | - | - | - | - | - |
Net cash provided by operating activities | ||||||||||
-841 | -2,119 | -2,838 | -472 | -3,497 | -3,216 | 1,137 | - | - | -3,549 | 445 |
Cash flows from investing activities | ||||||||||
Acquisition of product license | ||||||||||
- | - | - | - | - | - | - | - | - | 1,000 | 0 |
Net proceeds from the sale of assets | ||||||||||
- | - | 40,825 | 0 | 9 | 6 | 0 | 0 | 166 | 0 | 480 |
Purchase of marketable securities | ||||||||||
3,137 | 13,350 | 31,693 | 0 | 0 | - | - | - | - | - | - |
Proceeds from sale of marketable debt securities | ||||||||||
- | 14,280 | 12,850 | - | - | - | - | - | - | - | - |
Proceeds from sale of marketable debt securities | ||||||||||
8,908 | 11,071 | - | 0 | 0 | - | - | - | - | - | - |
Capital expenditures | ||||||||||
228 | 140 | - | - | - | - | - | - | - | - | - |
Net cash provided by operating activities | ||||||||||
- | - | - | - | - | - | - | -5,729 | -2,108 | - | - |
Capital expenditures | ||||||||||
- | - | 208 | 651 | 718 | 312 | 442 | 310 | 300 | 153 | 208 |
Net cash provided by (used in) investing activities | ||||||||||
5,543 | 11,862 | 21,774 | -651 | -709 | -306 | -442 | - | - | -1,153 | 272 |
Cash flows from financing activities | ||||||||||
Payment of dividends | ||||||||||
5,822 | 11,700 | - | - | - | - | - | - | - | - | - |
Payments to retire notes | ||||||||||
- | - | 1,500 | 0 | 0 | - | - | - | - | - | - |
Payments to acquire treasury stock | ||||||||||
- | - | 16,283 | 0 | 0 | - | - | - | - | - | - |
Proceeds for warrants exercised | ||||||||||
- | - | 69 | 0 | 0 | - | - | - | - | - | - |
Proceeds from exercise of stock options | ||||||||||
- | 337 | 1,510 | 0 | 0 | - | 27 | 0 | 0 | 133 | 127 |
Proceeds from issuance of common stock | ||||||||||
- | - | - | 0 | 1,564 | 4,910 | 444 | 1,070 | 0 | 0 | - |
Payment of long term obligation | ||||||||||
- | - | - | 100 | 100 | 100 | 100 | 0 | - | - | - |
Secured promissory note issuance costs | ||||||||||
- | - | - | 0 | 20 | 0 | 0 | - | - | - | - |
Proceeds from secured promissory note | ||||||||||
- | - | - | 0 | 1,500 | 0 | 0 | - | - | - | - |
Net cash used in financing activities | ||||||||||
-5,822 | -11,362 | -16,204 | -100 | 2,944 | 4,810 | 371 | -310 | -134 | 133 | 127 |
Increase in cash and cash equivalents | ||||||||||
-1,120 | -1,619 | 2,732 | -1,223 | -1,262 | 1,288 | 1,066 | -4,969 | -2,691 | -4,569 | 844 |
Purchase of treasury stock | ||||||||||
- | - | - | - | - | - | - | - | 449 | 0 | 0 |
Net cash provided by financing activities | ||||||||||
- | - | - | - | - | - | - | 1,070 | -449 | - | - |
Supplemental disclosures: | ||||||||||
Cash paid for interest | ||||||||||
- | - | 54 | 190 | 6 | - | - | - | - | - | - |
Cash paid for income taxes | ||||||||||
103 | - | 1,350 | 0 | 0 | - | - | - | 0 | 34 | 43 |
Interest paid | ||||||||||
- | - | - | - | - | 10 | 13 | 0 | 0 | - | - |
Issuance of warrants in connection with secured promissory notes | ||||||||||
- | - | - | 0 | 14 | 0 | - | - | - | - | - |
Supplemental disclosure of non-cash investing and financing activities: | ||||||||||
Unrealized gain on marketable debt securities | ||||||||||
22 | 54 | -78 | 0 | 0 | - | - | - | - | - | - |
Escrow receivable | ||||||||||
- | - | 5,000 | 0 | 0 | - | - | - | - | - | - |
Treasury stock acquired pursuant to a settlement agreement | ||||||||||
- | - | - | - | - | 5,105 | 0 | 0 | - | - | - |
Common stock issued to Phosphagenics Limited pursuant to a product license agreement | ||||||||||
- | - | - | - | - | - | - | - | - | 2,577 | 0 |
Common stock issued, in lieu of cash, as payment for service | ||||||||||
- | - | - | - | - | 393 | 0 | 0 | 294 | 0 | 0 |